---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299238433.md"
description: "During Wednesday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Basel Medical Group (+14.1%), Alaunos Therapeutics (+12.49%), and Genenta Science (+9.05%). Conversely, losers featured Rocket One (-9.6%), BioCardia (-8.01%), and Tempest Therapeutics (-7.44%). The report highlights specific price movements and market capitalizations for these listed companies."
datetime: "2026-09-16T21:06:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299238433.md)
  - [en](https://longbridge.com/en/news/299238433.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299238433.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **Basel Medical Group** (NASDAQ:BMGL) stock moved upwards by 14.1% to $4.68 during Wednesday's after-market session. The market value of their outstanding shares is at $8.3 million.
-   **Alaunos Therapeutics** (NASDAQ:TCRT) shares moved upwards by 12.49% to $1.44. The market value of their outstanding shares is at $3.5 million.
-   **Genenta Science** (NASDAQ:GNTA) shares rose 9.05% to $0.78. The market value of their outstanding shares is at $19.4 million.
-   **Q/C Technologies** (NASDAQ:QCLS) shares rose 8.92% to $1.05. The company's market cap stands at $3.6 million.
-   **Alterity Therapeutics** (NASDAQ:ATHE) stock moved upwards by 8.41% to $4.12. The market value of their outstanding shares is at $63.7 million.
-   **Pomdoctor** (NASDAQ:POM) shares increased by 7.96% to $0.85. The market value of their outstanding shares is at $6.9 million.

### Losers

-   **Rocket One** (NASDAQ:RKTO) shares declined by 9.6% to $0.82 during Wednesday's after-market session. The market value of their outstanding shares is at $18.3 million.
-   **BioCardia** (NASDAQ:BCDA) stock decreased by 8.01% to $1.15. The market value of their outstanding shares is at $18.6 million.
-   **Tempest Therapeutics** (NASDAQ:TPST) stock fell 7.44% to $1.12. The company's market cap stands at $12.4 million.
-   **iTonic Holdings** (NASDAQ:ITOC) stock decreased by 7.17% to $0.28. The company's market cap stands at $5.0 million.
-   **PRF Technologies** (NASDAQ:PRFX) stock fell 6.42% to $0.95. The market value of their outstanding shares is at $3.1 million.
-   **ALPS Group** (NASDAQ:ALPS) shares decreased by 5.76% to $0.38. The company's market cap stands at $66.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [BCDA.US](https://longbridge.com/en/quote/BCDA.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [TPST.US](https://longbridge.com/en/quote/TPST.US.md)
- [TCRT.US](https://longbridge.com/en/quote/TCRT.US.md)
- [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md)
- [SAEN.US](https://longbridge.com/en/quote/SAEN.US.md)
- [QCLS.US](https://longbridge.com/en/quote/QCLS.US.md)
- [ATHE.US](https://longbridge.com/en/quote/ATHE.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [RKTO.US](https://longbridge.com/en/quote/RKTO.US.md)
- [ITOC.US](https://longbridge.com/en/quote/ITOC.US.md)
- [PRFX.US](https://longbridge.com/en/quote/PRFX.US.md)
- [ALPS.US](https://longbridge.com/en/quote/ALPS.US.md)
- [ALPWF.US](https://longbridge.com/en/quote/ALPWF.US.md)

## Related News & Research

- [TPST: Minimal cash and Nasdaq risk overshadow an expanded CAR-T pipeline](https://longbridge.com/en/news/305511993.md)
- [Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update | TPST Stock News](https://longbridge.com/en/news/305508795.md)
- [Tempest Therapeutics Holds Special Stockholder Meeting](https://longbridge.com/en/news/305721141.md)
- [TCRT: VLR199 and VLR360 are planned for 2027 clinical entry, with 2028 proof-of-concept targets](https://longbridge.com/en/news/305811501.md)
- [BioCardia Q3 2026 net loss widens 20% to $1.8 million](https://longbridge.com/en/news/305372315.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**